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Volume 52, Number 3 Abstracts 811thoracic graft with subsequent femoral access for the EVAR. Two patients
required left subclavian coverage, and three patients had full coverage of the
thoracic aorta. Only one patient had internal iliac artery (unilateral) cover-
age. Mean follow up was 22 months (range, 1-72 months), with 100%
survival. No patients developedMI, respiratory failure, or acute renal failure.
The mean preoperative creatinine (1.18  0.16) and mean postoperative
creatinine (1.14  0.22) remained unchanged (95% CI, –0.242 to 0.322; P
 .752). No patients developed neurologic complications, including paral-
ysis or stroke. Mean blood loss was 360  119 mL. There were no access
complications, and all arteriotomies were closed primarily. The average ICU
stay was 3 days, and the average hospital stay was 8 days. In follow-up, one
patient developed a type II endoleak with no intervention due to continued
sac shrinkage.
Conclusion:Combined TEVAR and EVAR can be performed success-
fully with minimal morbidity and mortality. In particular, no patients suf-
fered lower extremity paralysis or renal failure despite a high proportion of
emergent cases.
Root Cause of Fortron Suprarenal Stent Fractures
Jonathon A. Rubin, MD, Zhonghua Li, PhD and Bruce J. Brener, MD,
Newark Beth Israel Medical Center, Newark, NJ
Objective:Clinical experience has revealed that most nitinol AAA stent
grafts suffer from suprarenal stent fracture that could potentially result in
caudal prosthesis migration and/or type I endoleak. There is limited under-
standing of the mechanism of suprarenal stent fracture. The aim of this study
was to investigate the root cause of fracture based on theoretical analysis, in
vitro testing, in vivo image observation, and clinical follow-up.
Methods: Suprarenal stent-to-artery interaction, force translation, ax-
ial motion, and fracture mechanism based on finite element analysis (FEA)
and structural theory were established. In vitro fatigue tests under different
loading modes (axial, radial, twisting, and bending) were performed for 30
devices on Bose ELF and SGT testers with 10 MM cycles. Dynamic CT
imaging data sets were analyzed on 13 patients with AAA devices to observe
and measure specific three-dimensional device deformations and motions
over the cardiac cycle. In addition, clinical follow-up results from the
Fortron AAA stent graft pivotal study were analyzed by a core laboratory.
Results: Bench testing and FEA both indicated that radial pulsatile
torsion and bending did not result in suprarenal stent fracture. However,
1.0-mm axial motion along the aorta could cause fracture anywhere along
the stent frame, 0.5-mm axial motion resulted in one fracture, no fracture
occurred at 0.3 mm, and the estimated minimal threshold was 0.5 mm. FEA
revealed that the axial motion for most AAA patients ranges from 0.37 to
0.49 mm. Dynamic CT imaging, however, showed a maximum axial motion
of 0.9 mm, which exceeded the threshold of 0.5 mm. Clinically, the Fortron
AAA suprarenal stent fracture rate for patients without increased neck
angulations or difficult anatomy at 12 and 48 months were 5.9% (11 of 168)
and 23.2% (35 of 84), respectively.
Conclusions: The suprarenal stent pulsatile axial motion translated from
aorta is the root cause of stent fracture, with implications to suprarenal stent
design.Mitigating axialmotion, increasing stent column strength, and optimiz-
ing the structure to improve its fatigue resistance are the applicable approaches.
Evaluating Preventable Adverse Events: Patient Safety After Elective
Lower Extremity Procedures
Todd R. Vogel, Viktor Y. Dombrovskiy, MD PhD MPH, Paul B. Haser,
Jeffrey L. Carson, MD, and Alan M. Graham, MD, UMDNJ-Robert Wood
Johnson Medical School, New Brunswick, NJ
Objective: Improving patient safety has become a national priority.
Patient Safety Indicators (PSIs) are validated tools to identify potentially
preventable adverse events. No studies exist evaluating lower extremity (LE)
vascular procedures and the occurrence of PSIs.
Methods: The Nationwide Inpatient Sample (2003-2007) was que-
ried for elective LE angioplasty (endo) and bypass (open). PSIs appropriate
to surgery were analyzed by 2 and logistic regression analyses.
Results: A total of 226,501 LE interventions (104,491 endo; 122,010
open) were evaluated. The rate of developing any PSI was 8.51% (endo) and
7.74% (open; P .0001). Adjusted by age, gender, race, and comorbidities,
odds ratios for PSIs are graphed. PSI predictors were age (OR, 1.64; 95%CI,
1.55-1.75), females (OR, 1.18; 95% CI, 1.13-1.22), blacks (OR, 1.10; 95%
CI, 1.04-1.17), congestive heart failure (OR, 1.83; 95% CI, 1.72-1.96),
diabetes (OR, 1.20; 95% CI, 1.12-1.28), renal failure (OR, 2.31; 95% CI,
2.14-2.50), hospital teaching status (OR, 1.21; 95% CI, 1.17-1.26), and
larger hospitals (OR, 1.11; 95% CI, 1.05-1.17). PSI occurrence was associ-
ated with a significant increase in cost ($28,387 vs $13,278; P  .0001).
Conclusions: Although deemed “safer and less invasive,” a greater
number of safety events occurred with endovascular procedures, primarily
due to bleeding complications in women and the elderly. PSIs were associ-
ated with advanced age, black race, and comorbidities. Adverse events added
significant cost and occurredmore frequently in teaching and large hospitals.
Future organizational analysis may improve safety and reduce cost.Patients with Hypertension Have a High Incidence of Peripheral
Arterial Disease Correlating With the Severity of Their Hypertension
David Reznick, MS, John Blebea, MD, John Wang, MD, Michael Smith,
MD, and Eric Yasinow, MD, Case Western Reserve University, Cleveland,
Ohio
Objectives: Although it is well established that patients with peripheral
arterial disease (PAD) have a higher incidence of hypertension (HTN),
studies have not examined if patients with HTN are at higher risk for PAD.
We prospectively investigated the incidence of PAD as a function of the
severity of HTN.
Methods: Patients seen at an internal medicine practice were screened
for the presence of HTN by history, use of antihypertensive medications, or
a blood pressure160/85 mmHg. The number and dose of antihyperten-
sive medications were recorded and patients’ blood pressure and bilateral
ankle-brachial indexes (ABI) were measured.
Results: A total of 116 patients (52 men, 64 women), with a mean age
of 64  2 years and HTN of 14  1 years’ duration, were prospectively
identified. Significant cardiovascular risk factors included hypercholesterol-
emia in 65%, cardiac dysfunction in 33%, smoking in 61% (24  2 pack-
years), renal insufficiency in 40% (creatinine 2.2  0.2 mg/dL), and diabe-
tes mellitus in 34% (HbgA1C 7.2%  0.2%). Mean systolic blood pressure
was 149  3 mm Hg while on three antihypertensive medications. More
than half of the patients, 61%, were still hypertensive with systolic pressures
140 mm Hg, whereas 20% were 160 mm Hg. The mean ABI for the
entire group was 0.98  0.03, with 28% of patients falling 0.90 and an
additional 3% with noncompressible vessels. There was a significant inverse
correlation between the systolic blood pressure and ABI, with higher blood
pressure correlating with a lower ABI (P  .005). Patients with a blood
pressure160mmHg had a significantly lower ABI than those with a lower
pressure, 0.89  0.05 vs 1.02  0.02 (P  .005).
Conclusions: Patients with hypertension have a high incidence of
peripheral arterial disease. The severity of PAD is significantly and propor-
tionately correlated with elevated HTN. Patients with a systolic blood
pressure 160 mm Hg are at particular risk of PAD and should be consid-
ered for further evaluation through measurement of the ABI or vascular
laboratory testing.
Prevalence and Effects of BMI on Hospital Course, 30-Day Mortality,
and Morbidity in Patients Undergoing Endovascular Procedures
Hafiz G. Hussain, MD, Sikandar Z. Khan, MD, Muhammad A. Khan, MD,
Ashley R. Graham, MD, and James F. McKinsey, MD, New York Presbyte-
rian Hospital, New York, NY
Objectives: Obesity is common in patients presenting with vascular
diseases and has been associated with increased perioperative complications
with open surgical procedures, but the effect of body mass index (BMI) on
endovascular procedures is uncertain. This study was to determine the effect
of BMI on hospital course and 30-day mortality and morbidity on patients
undergoing endovascular surgical procedures.
Methods: We identified 2023 endovascular procedures in 1642 pa-
tients (2003-2009) from our prospectively maintained database. These
procedures included 1380 lower extremity revascularizations (LER), 450
endovascular aneurysm repairs (EVAR), and 193 carotid artery stenting
(CAS). Patients were stratified using the WHO classification of obesity into
underweight (BMI 18.5), normal (BMI, 18.5-24.9), overweight (BMI,
25.0-29.9), and obese (BMI30.0). Length of surgery (LOS), PACU stay
(LOP), hospitalization (LOH), amount of blood loss (EBL), 30-day mor-
tality, and morbidity were analyzed using regression analysis
Results: Patient population included 548 normal (35.5%), 48 under-
weight (2.2%), 626 overweight (38.15%), and 385 obese (23.1%). Over-
weight and obese patients had significantly higher diabetes (P 0.001) and
